Advertisement
Skip to Content
Morningstar

Green Thumb Industries Inc GTBIF Stock Quote

Morningstar Rating
| Rating as of

PINX: GTBIF

Last close prices updated as of Jan 30, 2023, 4:00 PM EST | USD
  • Last Close 7.51
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Growth
  • Day Range 7.50  –  7.67
  • Year Range 7.40  –  22.46
  • Market Cap 1.7751 Bil
  • Volume / Avg 1.4 Mil /  559,951.7
  • Price / Sales 1.77
  • Price / Book 1.04
  • Forward Div Yield —
  • Trailing Div Yield —

Morningstar‘s Stock Analysis GTBIF

Valuation
Currency in —
Is it the right time to buy or sell?
Find out with Morningstar Investor
Is it the right time to buy or sell?
Find out with Morningstar Investor

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Green Thumb Remains Well Positioned for Expanding Cannabis Legalization Despite Near-Term Challenges

Business Strategy and Outlook

| Kristoffer Inton |

Green Thumb Industries cultivates and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. Unlike its Canadian peers, the firm is more vertically integrated as it owns dispensaries in addition to the cultivation and processing of value-added products. It has a presence in 15 states through 17 production facilities, 77 stores, and six brands. In states with more mature cannabis markets, Green Thumb believes there are enough cultivators available and purchases cannabis from third parties. This helps reduce capital intensity for expansion without sacrificing exposure to widening legalization.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics GTBIF

More

Company Profile GTBIF

Business Description

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 75 cannabis stores under the chains Rise and Essence. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.

Contact
325 West Huron Street, Suite 412
Chicago, IL, 60654
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Employees 3,800

Related Articles GTBIF

Stock Analyst Update

Cannabis Stocks Rally on Legalization Optimism After Biden’s Pardons, but Still Undervalued

Changes to current federal law could allow U.S. cannabis operators to pay lower taxes, access traditional banking services, and list on major stock exchanges.
Kristoffer Inton
Sustainability Matters

Hate the Sin, Love the Stock: Investors’ ESG Exclusions Leave Opportunities

Undervalued shares include AB InBev, Boston Beer, Imperial Brands, and Roblox.
Kristoffer Inton
US Videos

Will Cannabis Stocks Revive in 2022?

There's plenty of opportunity for these stocks after a rough 2021.
Kristoffer Inton
US Videos

Cannabis' Federal Legal Status Is Not a Total Buzzkill

The industry still has significant growth potential.
Karen Wallace
Stock Strategist Industry Reports

Still a Long Road to Legalizing Cannabis Federally

But investors can still find value in U.S. cannabis stocks.
Kristoffer Inton
Stock Analyst Update

Cannabis Stocks Rally on Schumer’s Push for Legislation

Legalization doesn’t change our estimated market potential of $85 billion by 2030.
Kristoffer Inton
Stock Analyst Update

Cannabis Stocks Rally from Senate Results

Despite the rally, actual economic exposure differs widely.
Kristoffer Inton
Stock Analyst Update

Which Stocks Will Benefit from Cannabis' Landslide Win?

Every ballot measure was approved.
Kristoffer Inton

Related News GTBIF

More

FAQs for Green Thumb Industries Inc Stock

No. GTBIF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

GTBIF’s market cap is 1.78 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

GTBIF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

GTBIF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare GTBIF’s historical performance against its industry peers and the overall market.